Design and selection of peptides to block the SARS-CoV-2 receptor binding domain by molecular docking.
Ontology highlight
ABSTRACT: The novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is currently one of the most contagious viruses in existence and the cause of the worst pandemic in this century, COVID-19. SARS-CoV-2 infection begins with the recognition of the cellular receptor angiotensin converting enzyme-2 by its spike glycoprotein receptor-binding domain (RBD). Thus, the use of small peptides to neutralize the infective mechanism of SARS-CoV-2 through the RBD is an interesting strategy. The binding ability of 104 peptides (University of Nebraska Medical Center's Antimicrobial Peptide Database) to the RBD was assessed using molecular docking. Based on the molecular docking results, peptides with great affinity to the RBD were selected. The most common amino acids involved in the recognition of th
SUBMITTER: Ramirez-Acosta K
PROVIDER: S-EPMC9344557 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA